 Your new post is loading...
Your new post is loading...
Scoop.it!
CLMC 2014 - 2015 CSCC Canadian Congress of Laboratory Medicine (CLMC) (2015 CSCC Canadian Congress of Laboratory Medicine (CLMC) http://t.co/gaDL5LbVHO ReseachBib)... 
No comment yet.
Sign up to comment
Scoop.it!
CellaVision is this year's winner of PhotonicSweden's industry award for its contribution to the laboratory medicine industry due to its technology strength within the field of Optics and Photonics and successful business ...
Scoop.it!
Opinion: For-profit hospital labs simply don't work
Scoop.it!
Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017
Scoop.it!
ASCP President Steven Kroft, MD, FASCP discusses the challenges and opportunities facing pathology and laboratory medicine in this evolving climate.
Scoop.it!
Les chercheurs toulousains viennent de breveter une nouvelle technique de dosage du bon cholestérol dans le sang. Ce marqueur appelé IF1 (Inhibitory Factor One) a été testé avec succès sur 1 317 patients. Les résultats ont été publiés dans la prestigieuse revue américaine le « Journal of Lipid Research ». Les équipes poursuivent leurs travaux afin de généraliser le dosage à l’ensemble des patients. Le dépistage du mauvais cholestérol, ces mauvaises graisses LDL qui s’accumulent sous forme de plaques dans nos artères et finissent par les obstruer, est essentiel pour connaître le risque individuel de maladies cardiovasculaires. Or, rappellent les cardiologues, il est tout aussi indispensable de connaître avec précision le taux de bon cholestérol (HDL). En effet, une carence en bon cholestérol exprime un risque aggravé d’athérosclérose (dépôt de lipides sur la paroi des artères) - même si le mauvais cholestérol, a pu être stabilisé par différentes thérapeutiques, dont les statines. Réalisé en routine, le dosage du bon cholestérol ne bénéficiait pas d’un marqueur assez précis et fiable ; une mesure imparfaite qui ne fournissait pas d’information prédictive de maladies coronariennes. Via JIB Biology
Scoop.it!
Bioscience Technology
Gilbert C FAURE's insight:
from genes to immunologically involved molecules
Scoop.it!
Complement protein holds diagnostic, prognostic promise in lung cancer
Scoop.it!
Our team of experts have created this comprehensive resource of practical laboratory and transfusion information for healthcare providers and patients.
Scoop.it!
Direct-to-consumer testing: Taking the doctor out of the doctor's orders?
Scoop.it!
Articulate - The leader in rapid e-learning and communications.
Scoop.it!
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
Scoop.it!
Shrinking Laboratory-Scale Processes
Scoop.it!
C40-A2 is intended for members of the clinical laboratory testing community involved in the collection and measurement of lead in blood and urine. C40-A2 provides direction for specimen collection, measurement by graphite ...
Scoop.it!
The Evolving IVD Reimbursement Landscape in 2013 Medical Device and Diagnostics Industry (blog) Despite unprecedented advances in laboratory medicine, the Medicare agency is dealing with the in vitro diagnostics boom with an unprecedented series of...
Scoop.it!
Monitoring Anti-TNF alpha Biotherapy to Customise Patient Treatment SelectScience.net (press release) A new range of Theranostic Assays is now available in the UK, exclusively from Alpha Laboratories, that will help clinicians to tailor individual...
Scoop.it!
New look at old test may provide earlier detection of meningitis, MU ...
Scoop.it!
Professional society for laboratory personnel. Courses, publications and events.
Scoop.it!
Corgenix Announces Diagnostic Test Development Partnership with Health ...
Scoop.it!
WXYZ Blood test for pancreatic cancer shows promise Health24.com The researchers said the results were much more impressive than, for example, the prostate-specific antigen (PSA) test used to screen for prostate cancer, which has roughly a 20%...
Scoop.it!
Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay ...
Scoop.it!
No time for Quality? Reasons to Reevaluate and Reinvest in a Lab Quality Program : September-October 2013 - MLM Magazine - Peer-to-Peer Information Source for Clinical Lab Management Via Alfredo Corell
Gilbert C FAURE's insight:
quality is a state of mind, andshould not be an administrative coercition
Alfredo Corell's curator insight,
October 27, 2013 7:00 PM
Poor quality in the lab not only forces an organization into a reactive mode of problem solving, but it also creates a higher cost burden than a laboratory with an effective quality infrastructure experiences. Reruns performed due to quality control failures can significantly increase testing costs and cut into a lab’s bottom line. Furthermore, according to a recent study, correction of errors across all phases of laboratory testing can consume 12-35 percent of technician time.
Scoop.it!
Laboratory Medicine: The Diagnosis of Disease in the Clinical Laboratory (LANGE Basic Science) [Michael Laposata] on Amazon.com. *FREE* super saver shipping on qualifying offers.
Gilbert C FAURE's insight:
are you interested in books relative to the topic?
Scoop.it!
Even as only a small number of clinical laboratories in the United States have taken the steps to earn accreditation to ISO 15189 Medical Laboratories, it is a different story in other nations, particularly where no statutory requirement for...
|
